As Genzyme flounders, competitors and activist investors swoop in.
Allison
Malorye
M
D019149:Bioreactors / Q000821:virology; D004340:Drug Contamination; D004345:Drug Industry / Q000191:economics* / Q000592:standards*; D004465:Economic Competition; D006801:Humans; D007449:Investments; D011786:Quality Control; D014481:United States; D014486:United States Food and Drug Administration